N. Martínez

Assessment of nucleotide excision repair XPD polymorphisms in the peripheral blood of gemcitabine/cisplatin-treated advanced non-small-cell lung cancer patients.

R. Rosell, J. Sánchez, C. Camps, 2003, Clinical lung cancer.

Zoledronic acid in lung cancer with bone metastases: a review

J. Bosch-Barrera, N. Martínez, D. Isla, 2013, Expert review of anticancer therapy.

Primary Breast Lymphoma: Analysis of 55 Cases of the Spanish Lymphoma Oncology Group

M. Provencio, M. Torrente, A. Royuela, 2017, Clinical lymphoma, myeloma & leukemia.

Prospective Exploratory Analysis of Angiogenic Biomarkers in Peripheral Blood in Advanced NSCLC Patients Treated With Bevacizumab Plus Chemotherapy: The ANGIOMET Study

R. Rosell, M. Guillot, C. Rolfo, 2021, Frontiers in Oncology.

Prognostic value of event‐free survival at 12 and 24 months and long‐term mortality for non‐Hodgkin follicular lymphoma patients: A study report from the Spanish Lymphoma Oncology Group

V. Calvo, M. Provencio, M. Pollán, 2017, Cancer.

Impact of treatment in long-term survival patients with follicular lymphoma: A Spanish Lymphoma Oncology Group registry

J. Sánchez, V. Calvo, M. Provencio, 2017, PloS one.

Impact of CGA in therapeutic decisions: ELDERLY trial.

N. Martínez, J. G. Plazas, E. Martinez, 2015 .

Monitoring of Circulating Tumor DNA Predicts Response to Treatment and Early Progression in Follicular Lymphoma: Results of a Prospective Pilot Study

M. Sánchez-Beato, V. Calvo, M. Provencio, 2022, Clinical cancer research : an official journal of the American Association for Cancer Research.